TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
ALBHF Stock 12 Month Forecast
Average Price Target
$0.90
▲(18.42% Upside)
Based on 9 Wall Street analysts offering 12 month price targets for Alibaba Health Information Technology in the last 3 months. The average price target is $0.90 with a high forecast of $1.55 and a low forecast of $0.59. The average price target represents a 18.42% change from the last price of $0.76.
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$0.73
Buy
-4.28%
Downside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.78
Buy
2.28%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
Unknown Analyst
CICC
Not Ranked
CICC
$0.91
Buy
19.44%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
Analysts Conflicted on These Healthcare Names: Merck & Company (NYSE: MRK), Alibaba Health Information Technology (Other OTC: ALBHF) and Janux Therapeutics Inc (NASDAQ: JANX)
Unknown Analyst
Guotai Haitong
Not Ranked
Guotai Haitong
$0.73
Buy
-4.28%
Downside
Reiterated
12/03/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from Guotai Haitong
Unknown Analyst
Huatai Securities
Not Ranked
Huatai Securities
$0.78
Buy
2.28%
Upside
Reiterated
11/30/25
Huatai Securities Remains a Buy on Alibaba Health Information Technology (ALBHF)
Unknown Analyst
CICC
Not Ranked
CICC
$0.91
Buy
19.44%
Upside
Reiterated
11/28/25
Alibaba Health Information Technology (ALBHF) Gets a Buy from CICC
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +0.90% per trade.
Copying PerPlexity Medical - Pharmaceuticals's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +7.00% per trade.
trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +0.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
ALBHF Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Dec 25
Jan 26
Feb 26
Strong Buy
5
1
2
9
13
Buy
0
0
0
0
0
Hold
22
21
21
7
11
Sell
0
1
2
2
1
Strong Sell
0
0
0
0
0
total
27
23
25
18
25
In the current month, ALBHF has received 13Buy Ratings, 11Hold Ratings, and 1Sell Ratings. ALBHF average Analyst price target in the past 3 months is 0.90.
Each month's total comprises the sum of three months' worth of ratings.
ALBHF Financial Forecast
ALBHF Earnings Forecast
Next quarter’s earnings estimate for ALBHF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was $0.01. ALBHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
Next quarter’s earnings estimate for ALBHF is <$0.01 with a range of <$0.01 to <$0.01. The previous quarter’s EPS was $0.01. ALBHF beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.43% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
ALBHF Sales Forecast
Next quarter’s sales forecast for ALBHF is $2.63B with a range of $2.61B to $2.66B. The previous quarter’s sales results were $2.33B. ALBHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
Next quarter’s sales forecast for ALBHF is $2.63B with a range of $2.61B to $2.66B. The previous quarter’s sales results were $2.33B. ALBHF beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 49.17% of the time in the same period. In the last calendar year ALBHF has Performed in-line its overall industry.
ALBHF Stock Forecast FAQ
What is ALBHF’s average 12-month price target, according to analysts?
Based on analyst ratings, Alibaba Health Information Technology Ltd.’s 12-month average price target is 0.90.
What is ALBHF’s upside potential, based on the analysts’ average price target?
Alibaba Health Information Technology Ltd. has 18.42% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is ALBHF a Buy, Sell or Hold?
Alibaba Health Information Technology Ltd. has a consensus rating of Moderate Buy which is based on 6 buy ratings, 2 hold ratings and 1 sell ratings.
What is Alibaba Health Information Technology Ltd.’s price target?
The average price target for Alibaba Health Information Technology Ltd. is 0.90. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst price target is $1.55 ,the lowest forecast is $0.59. The average price target represents 18.42% Increase from the current price of $0.76.
What do analysts say about Alibaba Health Information Technology Ltd.?
Alibaba Health Information Technology Ltd.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of ALBHF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.